Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
26.22
-0.18 (-0.68%)
Nov 21, 2024, 4:00 PM EST - Market closed
Celldex Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,740 | 2,169 | 2,099 | 1,803 | 693 | 37 | |
| Market Cap Growth | 73.23% | 3.32% | 16.42% | 160.10% | 1759.97% | 9.20% | |
| Enterprise Value | 999 | 1,936 | 1,779 | 1,383 | 497 | -32 | |
| Last Close Price | 26.40 | 39.66 | 44.57 | 38.64 | 17.52 | 2.23 | |
| PS Ratio | 160.95 | 315.12 | 890.64 | 387.68 | 93.45 | 10.43 | |
| PB Ratio | 2.23 | 5.05 | 6.44 | 4.30 | 3.31 | 0.40 | |
| P/TBV Ratio | 2.97 | 5.40 | 7.02 | 4.60 | 3.88 | 0.82 | |
| EV/Sales Ratio | 100.10 | 281.34 | 754.94 | 297.37 | 67.06 | - | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | |
| Asset Turnover | 0.02 | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | |
| Quick Ratio | 23.58 | 13.69 | 16.41 | 24.71 | 13.81 | 5.62 | |
| Current Ratio | 24.27 | 13.87 | 17.07 | 24.86 | 13.93 | 5.73 | |
| Return on Equity (ROE) | -29.84% | -37.45% | -30.13% | -22.43% | -39.41% | -46.66% | |
| Return on Assets (ROA) | -19.73% | -21.70% | -16.79% | -12.70% | -17.27% | -24.45% | |
| Return on Capital (ROIC) | -20.96% | -23.30% | -17.78% | -13.60% | -19.96% | -30.74% | |
| Earnings Yield | -8.76% | -6.52% | -5.35% | -3.91% | -8.62% | -136.51% | |
| FCF Yield | -9.08% | -5.03% | -5.03% | -3.45% | -6.05% | -126.50% | |
| Buyback Yield / Dilution | -28.81% | -3.33% | -9.37% | -44.64% | -104.32% | -38.93% | |
| Total Shareholder Return | -28.81% | -3.33% | -9.37% | -44.64% | -104.32% | -38.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.